Chemoinformaics analysis of 1-HYDROXY-3,6,8-TRIMETHOXYXANTHEN-9-ONE
| Molecular Weight | 302.282 | nRot | 3 |
| Heavy Atom Molecular Weight | 288.17 | nRig | 17 |
| Exact Molecular Weight | 302.079 | nRing | 3 |
| Solubility: LogS | -3.76 | nHRing | 1 |
| Solubility: LogP | 3.339 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 16 |
| nHA | 6 | APOL | 40.8671 |
| nHD | 1 | BPOL | 21.8569 |
| QED | 0.749 |
| Synth | 2.278 |
| Natural Product Likeliness | 1.067 |
| NR-PPAR-gamma | 0.94 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.782 |
| Pgp-sub | 0.005 |
| HIA | 0.018 |
| CACO-2 | -4.856 |
| MDCK | 0.0000306 |
| BBB | 0.024 |
| PPB | 0.816755 |
| VDSS | 1.018 |
| FU | 0.165699 |
| CYP1A2-inh | 0.971 |
| CYP1A2-sub | 0.973 |
| CYP2c19-inh | 0.706 |
| CYP2c19-sub | 0.528 |
| CYP2c9-inh | 0.612 |
| CYP2c9-sub | 0.942 |
| CYP2d6-inh | 0.713 |
| CYP2d6-sub | 0.929 |
| CYP3a4-inh | 0.476 |
| CYP3a4-sub | 0.206 |
| CL | 5.099 |
| T12 | 0.458 |
| hERG | 0.018 |
| Ames | 0.518 |
| ROA | 0.127 |
| SkinSen | 0.646 |
| Carcinogencity | 0.023 |
| EI | 0.978 |
| Respiratory | 0.476 |
| NR-Aromatase | 0.773 |
| Antiviral | Yes |
| Prediction | 0.727471 |